Medicare Prescription Drug Benefit: Utilization Management
Utilization management (UM) techniques (sometimes referred to as “benefit management tools”) are measures taken by prescription drug plans to control the access to or use of specific drugs. The Centers for Medicare and Medicaid Services (CMS) states that UM techniques for the new Medicare prescription drug coverage “must include incentives to reduce costs when medically appropriate and assist with preventing over-utilization and under-utilization of medications.”
Questions Answered
Yes, the new Medicare prescription drug plans will include several types of utilization management tools, including formularies; co-pay tiering; prior authorization; fail-first or step therapy; and promotion of lower cost generics. Although CMS has stated that it expects formulary drugs to be available in all dosages and forms, it is unclear whether this will actually be the case.
What are common types of utilization management?
Tiered co-pays: Drugs that are more expensive, such as brand name drugs, may be placed on higher tiers than others and may have higher co-pays associated with them (Dual eligible patients will have $1 or $3 co-pays).
Prior authorization: Specific drugs may require that the physician seek prior authorization from the prescription drug plan (PDP) before the prescription can be filled.
Promotion of lower cost generics or generic substitution: Plans might have a variety of promotion plans to encourage use of generic vs. brand name drugs, or may automatically switch prescriptions to generics when they are available.
Fail-first or Step therapy: This requires that a patient fail on one or more formulary drug, generally a lower price, or generic drug, before a prescription will be filled for the drug a physician has determined would be most appropriate/effective for the patient.
Quantity or dose limitation: Plans can limit filling prescriptions of certain drugs up to a specific quantity.
Off-label restrictions: Although many drugs are routinely used to treat conditions for which the FDA may not have approved them, this UM technique permits PDPs to cover drugs only for their FDA-approved uses.
How will I know which drugs are subject to UM policies and procedures?
Once prescription drug plans are approved and released by CMS, the various formularies and other utilization management techniques should be accessible online through a CMS search engine.
Will plans have quality assurance measures and systems?
Yes, and quality assurance measures and systems may include both concurrent and retrospective drug utilization review systems (DURs) that may assist with preventing and detecting inappropriate drug therapy and adverse drug interactions.
Plans will also be required to implement internal medication error identification and reduction systems.
Current as of 9-26-2005
Print this page
Email colleague
